Logo image of AWH

ASPIRA WOMEN'S HEALTH INC (AWH) Stock Fundamental Analysis

NASDAQ:AWH - Nasdaq - US04537Y2081 - Common Stock - Currency: USD

0.082  -0.01 (-12.49%)

After market: 0.0395 -0.04 (-51.83%)

Fundamental Rating

2

Overall AWH gets a fundamental rating of 2 out of 10. We evaluated AWH against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of AWH have multiple concerns. AWH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AWH has reported negative net income.
In the past year AWH has reported a negative cash flow from operations.
AWH had negative earnings in each of the past 5 years.
AWH had a negative operating cash flow in each of the past 5 years.
AWH Yearly Net Income VS EBIT VS OCF VS FCFAWH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

AWH has a Return On Assets of -238.46%. This is amonst the worse of the industry: AWH underperforms 94.24% of its industry peers.
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROIC N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AWH Yearly ROA, ROE, ROICAWH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 59.67%, AWH is in line with its industry, outperforming 58.64% of the companies in the same industry.
In the last couple of years the Gross Margin of AWH has grown nicely.
The Profit Margin and Operating Margin are not available for AWH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
AWH Yearly Profit, Operating, Gross MarginsAWH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

0

2. Health

2.1 Basic Checks

AWH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AWH has been increased compared to 1 year ago.
AWH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AWH is higher compared to a year ago.
AWH Yearly Shares OutstandingAWH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AWH Yearly Total Debt VS Total AssetsAWH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

AWH has an Altman-Z score of -143.66. This is a bad value and indicates that AWH is not financially healthy and even has some risk of bankruptcy.
AWH has a worse Altman-Z score (-143.66) than 96.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -143.66
ROIC/WACCN/A
WACC7.54%
AWH Yearly LT Debt VS Equity VS FCFAWH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.76 indicates that AWH may have some problems paying its short term obligations.
The Current ratio of AWH (0.76) is worse than 91.62% of its industry peers.
AWH has a Quick Ratio of 0.76. This is a bad value and indicates that AWH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.71, AWH is not doing good in the industry: 87.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.71
AWH Yearly Current Assets VS Current LiabilitesAWH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

6

3. Growth

3.1 Past

AWH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.50%, which is quite impressive.
The Revenue has been growing slightly by 0.24% in the past year.
The Revenue has been growing by 15.13% on average over the past years. This is quite good.
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%

3.2 Future

The Earnings Per Share is expected to grow by 32.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, AWH will show a very strong growth in Revenue. The Revenue will grow by 64.54% on average per year.
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AWH Yearly Revenue VS EstimatesAWH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M
AWH Yearly EPS VS EstimatesAWH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6

1

4. Valuation

4.1 Price/Earnings Ratio

AWH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AWH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AWH Price Earnings VS Forward Price EarningsAWH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWH Per share dataAWH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as AWH's earnings are expected to grow with 32.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.55%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AWH!.
Industry RankSector Rank
Dividend Yield N/A

ASPIRA WOMEN'S HEALTH INC

NASDAQ:AWH (4/16/2025, 8:00:01 PM)

After market: 0.0395 -0.04 (-51.83%)

0.082

-0.01 (-12.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-13 2025-05-13/bmo
Inst Owners10.64%
Inst Owner Change-40.68%
Ins Owners13.72%
Ins Owner Change1.16%
Market Cap2.89M
Analysts80
Price Target5.61 (6741.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.81%
Min Revenue beat(2)-19.22%
Max Revenue beat(2)-18.41%
Revenue beat(4)0
Avg Revenue beat(4)-15.56%
Min Revenue beat(4)-19.22%
Max Revenue beat(4)-7.73%
Revenue beat(8)0
Avg Revenue beat(8)-15.76%
Revenue beat(12)0
Avg Revenue beat(12)-13.9%
Revenue beat(16)3
Avg Revenue beat(16)-9.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.26
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.67%
FCFM N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.22%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.71
Altman-Z -143.66
F-Score4
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)46.91%
Cap/Depr(5y)76.44%
Cap/Sales(3y)1.16%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%
EBIT growth 1Y13.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.79%
OCF growth 3YN/A
OCF growth 5YN/A